These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18484791)

  • 21. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weight gain associated with antipsychotic drugs.
    Ganguli R
    J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.
    Stigler KA; Potenza MN; Posey DJ; McDougle CJ
    Paediatr Drugs; 2004; 6(1):33-44. PubMed ID: 14969568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of weight gain associated with antipsychotics.
    Birt J
    Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.
    Gentile S
    Drug Saf; 2006; 29(4):303-19. PubMed ID: 16569080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.
    Das C; Mendez G; Jagasia S; Labbate LA
    Ann Clin Psychiatry; 2012 Aug; 24(3):225-39. PubMed ID: 22860242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Weight gain in patients with schizophrenia and schizoaffective disorder induced by the long-term treatment with atypical antipsychotics].
    Gorobets LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):52-6. PubMed ID: 18833173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of the effect of atypical antipsychotics on weight.
    Nasrallah H
    Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():83-96. PubMed ID: 12504074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy to limit weight gain caused by antipsychotic use.
    Malhi GS; Mitchell PB
    Expert Opin Pharmacother; 2003 Oct; 4(10):1679-86. PubMed ID: 14521478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.
    Stimmel GL; Gutierrez MA; Lee V
    Clin Ther; 2002 Jan; 24(1):21-37. PubMed ID: 11833834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
    N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole, a novel atypical antipsychotic drug.
    Argo TR; Carnahan RM; Perry PJ
    Pharmacotherapy; 2004 Feb; 24(2):212-28. PubMed ID: 14998222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
    Haefliger T; Bonsack C
    Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis.
    Bak M; Drukker M; Cortenraad S; Vandenberk E; Guloksuz S
    PLoS One; 2021; 16(2):e0244944. PubMed ID: 33596211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.